Attached files

file filename
EX-10.8 - EXHIBIT 10.8 - European Biotech Acquisition Corp.dp147296_ex1008.htm
EX-10.7 - EXHIBIT 10.7 - European Biotech Acquisition Corp.dp147296_ex1007.htm
EX-10.6 - EXHIBIT 10.6 - European Biotech Acquisition Corp.dp147296_ex1006.htm
EX-10.5 - EXHIBIT 10.5 - European Biotech Acquisition Corp.dp147296_ex1005.htm
EX-10.4 - EXHIBIT 10.4 - European Biotech Acquisition Corp.dp147296_ex1004.htm
EX-10.3 - EXHIBIT 10.3 - European Biotech Acquisition Corp.dp147296_ex1003.htm
EX-10.2 - EXHIBIT 10.2 - European Biotech Acquisition Corp.dp147296_ex1002.htm
EX-10.1 - EXHIBIT 10.1 - European Biotech Acquisition Corp.dp147296_ex1001.htm
EX-5.2 - EXHIBIT 5.2 - European Biotech Acquisition Corp.dp147296_ex0502.htm
EX-5.1 - EXHIBIT 5.1 - European Biotech Acquisition Corp.dp147296_ex0501.htm
EX-4.4 - EXHIBIT 4.4 - European Biotech Acquisition Corp.dp147296_ex0404.htm
EX-4.3 - EXHIBIT 4.3 - European Biotech Acquisition Corp.dp147296_ex0403.htm
EX-4.2 - EXHIBIT 4.2 - European Biotech Acquisition Corp.dp147296_ex0402.htm
EX-4.1 - EXHIBIT 4.1 - European Biotech Acquisition Corp.dp147296_ex0401.htm
EX-3.2 - EXHIBIT 3.2 - European Biotech Acquisition Corp.dp147296_ex0302.htm
EX-3.1 - EXHIBIT 3.1 - European Biotech Acquisition Corp.dp147296_ex0301.htm
EX-1.1 - EXHIBIT 1.1 - European Biotech Acquisition Corp.dp147296_ex0101.htm
S-1/A - FORM S-1/A - European Biotech Acquisition Corp.dp147296_s1a.htm

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in this Registration Statement of European Biotech Acquisition Corp. (the “Company”) on Amendment No. 1 to Form S-1 (File No. 333-253220) of our report dated February 5, 2021, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of European Biotech Acquisition Corp. as of January 18, 2021 and for the period from January 8, 2021 (inception) through January 18, 2021 appearing in the Registration Statement of the Company (File No. 333-253220).

 

/s/ Marcum llp

 

Marcum llp

New York, NY

March 4, 2021